Skip to main content
TipRanks
Go Ultimate75% OFF

Madrigal Pharmaceuticals (MDGL) Q2 2024 Earnings Report

1,368 Followers

MDGL Q2 2024 EPS Results

Actual EPS
-$7.10
Consensus EPS
-$7.54
Beat/Miss
Beat by +$0.44
One Year Ago EPS
-$4.69

MDGL Q2 2024 Revenue Results

Actual Revenue
$14.64M
Expected Revenue
$4.25M
Beat/Miss
Beat by +$10.38M
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2024
Date
08/07/2024
Time
Before Open
Conference Call
Wednesday, August 7, 2024
MDGL Upcoming Earnings

Madrigal Pharmaceuticals's next earnings date is estimated for February 25, 2027, based on past reporting schedules.

Q2 2024 Earnings Call Audio

MDGL Q2 2024 Earnings Call
0:00 / 0:00

Q2 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

MDGL Earnings History

MDGL earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 25, 20272026 (Q4)1.43--2.57――
Nov 03, 20262026 (Q3)-0.861.83-5.08136.02% (+6.91)
Jul 30, 20262026 (Q2)-2.68-1.99-1.9-4.74% (-0.09)
May 06, 20262026 (Q1)-4.23-3.25-3.322.11% (+0.07)
Feb 19, 20262025 (Q4)-0.90-2.57-2.715.17% (+0.14)
Nov 04, 20252025 (Q3)-2.29-5.08-4.92-3.25% (-0.16)
Aug 05, 20252025 (Q2)-3.55-1.90-7.173.24% (+5.20)
May 01, 20252025 (Q1)-3.75-3.32-7.3855.01% (+4.06)
Feb 26, 20252024 (Q4)-3.92-2.71-5.6852.29% (+2.97)
Oct 31, 20242024 (Q3)-6.75-4.92-5.347.87% (+0.42)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed